Literature DB >> 33301062

Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer.

He Zhang1, Guohui Qin2, Hui Yu3, Xu Han1, Sha Zhu4.   

Abstract

The aim of this study is to investigate the gene expression module of tumor-infiltrating CD4+T cells and its potential roles in modulating immune cell functions in triple-negative breast cancer. Differentially expressed genes were identified by comparison of the expression profile in CD4+T cells isolated from tumor tissues and peripheral blood of TNBC patients respectively. The differential expression analysis was conducted using R, and then the functional and pathway enrichment of the DEGs were analyzed using GSEA, followed by integrated regulatory network construction and genetic analysis of tumor-infiltrating immune cells based on a scientific deconvolution algorithm. As a result, abundant Treg and exhausted lymphocytes were detected, accompanied by largely decreased of effector/memory and cytotoxic T cells. Immune-related gene correlation analysis showed that the extent of follicular helper T cells gene expression signatures were inversely associated with those of CD4+ naive T cells and CD4+ memory resting T cells, but positively correlated with that of CD4+ memory activated T cells. In addition, we found five core genes including IFNG, CTLA4, FAS, CXCR6, and JUN were significantly over expressed in CD4+ TILs which may contribute to exhaustion of lymphocytes and participate in biological processes associated with regulation of chemotaxis. Study provides a comprehensive understanding of the roles of DEGs associated with the chemotactic and exhausted immunophenotypes of CD4+ TILs that are a valuable resource from which future investigation may be carried out to better understand the mechanisms that promote TNBC progression.

Entities:  

Keywords:  CD4+ T cell; Chemotaxis; Degs; Exhaustion; Gene expression profile; Tils

Mesh:

Substances:

Year:  2020        PMID: 33301062     DOI: 10.1007/s00262-020-02807-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  55 in total

1.  Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Authors:  Beatriz M Carreno; Vincent Magrini; Michelle Becker-Hapak; Saghar Kaabinejadian; Jasreet Hundal; Allegra A Petti; Amy Ly; Wen-Rong Lie; William H Hildebrand; Elaine R Mardis; Gerald P Linette
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

2.  Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.

Authors:  Hirofumi Matsumoto; Aye Aye Thike; Huihua Li; Joe Yeong; Si-Lin Koo; Rebecca Alexandra Dent; Puay Hoon Tan; Jabed Iqbal
Journal:  Breast Cancer Res Treat       Date:  2016-03-09       Impact factor: 4.872

3.  Modeling the specific CD4+ T cell response against a tumor neoantigen.

Authors:  Héloïse Flament; Ruby Alonso Ramirez; Virginie Prémel; Nathalie T Joncker; Alexandra Jacquet; Suzy Scholl; Olivier Lantz
Journal:  J Immunol       Date:  2015-03-02       Impact factor: 5.422

Review 4.  Breast cancer.

Authors:  Nadia Harbeck; Michael Gnant
Journal:  Lancet       Date:  2016-11-17       Impact factor: 79.321

Review 5.  Triple-negative breast cancer-Role of immunology: A systemic review.

Authors:  Gizem Oner; Sevilay Altintas; Zafer Canturk; Wiebren Tjalma; Yannick Verhoeven; Christophe Van Berckelaer; Zwi Berneman; Marc Peeters; Patrick Pauwels; Peter A van Dam
Journal:  Breast J       Date:  2019-12-04       Impact factor: 2.431

Review 6.  Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.

Authors:  Saman Bahrambeigi; Vahid Shafiei-Irannejad
Journal:  Biochem Pharmacol       Date:  2019-12-27       Impact factor: 5.858

Review 7.  Overcoming Tumor-Induced Immune Suppression: From Relieving Inhibition to Providing Costimulation with T Cell Agonists.

Authors:  Dana A Emerson; William L Redmond
Journal:  BioDrugs       Date:  2018-06       Impact factor: 5.807

8.  Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.

Authors:  Udaya K Liyanage; Todd T Moore; Hong-Gu Joo; Yoshiyuki Tanaka; Virginia Herrmann; Gerard Doherty; Jeffrey A Drebin; Steven M Strasberg; Timothy J Eberlein; Peter S Goedegebuure; David C Linehan
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

9.  CD4+ and Perivascular Foxp3+ T Cells in Glioma Correlate with Angiogenesis and Tumor Progression.

Authors:  Luyan Mu; Changlin Yang; Qiang Gao; Yu Long; Haitao Ge; Gabriel DeLeon; Linchun Jin; Yifan Emily Chang; Elias J Sayour; Jingjing Ji; Jie Jiang; Paul S Kubilis; Jiping Qi; Yunhe Gu; Jiabin Wang; Yuwen Song; Duane A Mitchell; Zhiguo Lin; Jianping Huang
Journal:  Front Immunol       Date:  2017-11-07       Impact factor: 7.561

10.  Association Between Metabolic Syndrome and Breast Cancer Risk: An Updated Meta-Analysis of Follow-Up Studies.

Authors:  Meng Guo; Tingting Liu; Peiting Li; Tianying Wang; Chen Zeng; Meng Yang; Gang Li; Jiang Han; Wei Wu; Ruopeng Zhang
Journal:  Front Oncol       Date:  2019-11-22       Impact factor: 6.244

View more
  4 in total

Review 1.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

2.  miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.

Authors:  Fanyi Meng; Man Yang; Yinshuang Chen; Weichang Chen; Weipeng Wang
Journal:  Cancer Immunol Immunother       Date:  2021-01-25       Impact factor: 6.968

3.  Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma.

Authors:  Shize Pan; Heng Meng; Tao Fan; Bo Hao; Congkuan Song; Donghang Li; Ning Li; Qing Geng
Journal:  Front Genet       Date:  2022-05-18       Impact factor: 4.772

4.  Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.

Authors:  Tao Fan; Shize Pan; Shuo Yang; Bo Hao; Lin Zhang; Donghang Li; Qing Geng
Journal:  Front Immunol       Date:  2021-08-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.